by PERIMETRIK® Bonn/Darmstadt | 12.12.2024
13:30 Â Â Development of new therapies based on alloreactive responses to AML (Paresh Vyas, Oxford) 13:55Â Â Short Talk 2: Acute myeloid leukemia with UBTF tandem duplications respond to combined BCL-2 and RNA polymerase I inhibition with increased stemless and a...
by PERIMETRIK® Bonn/Darmstadt | 12.12.2024
11:00   Welcome and Opening Remarks (Carsten Müller-Tidow, Heidelberg) 11:05   Novel stemness regulators in acute myeloid leukemia (Caroline Pabst, Heidelberg) 11:30   MAC-Scoring predicts AMLs outcome with HMA/Venetoclax (Simon Renders & Alexander Waclawiczek,...
by PERIMETRIK® Bonn/Darmstadt | 28.10.2024
About the Event Acute Myeloid Leukemia remains a difficult to treat disease. Leukemic stem cells are instrumental for disease pathogenesis. Stemness features also play a crucial role for therapy resistance and relapse. Novel approaches to target leukemic stem cells...
